Login / Signup

Association of immune checkpoint inhibitors therapy with arterial thromboembolic events in cancer patients: A retrospective cohort study.

Jie ZhuYue ChenYuanlong ZhangWei WangYujue WangZhuo LuYulin ZhangHaike LeiDairong LiBo LongHaixia Liu
Published in: Cancer medicine (2023)
ICI-treated patients may exhibit a higher risk of ATEs, especially after 1 year of treatment.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • ejection fraction
  • prognostic factors
  • atrial fibrillation
  • cell therapy
  • patient reported